Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31626
Title: Hyperoxemia in invasively ventilated COVID-19 patients-Insights from the PRoVENT-COVID study.
Austin Authors: Tsonas, A M;van Meenen, D M;Botta, M;Shrestha, G S;Roca, O;Paulus, F;Serpa Neto, Ary ;Schultz, M J
Affiliation: Department of Intensive Care, Amsterdam UMC, location 'AMC', Amsterdam, The Netherlands; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Australia
Department of Intensive Care, Amsterdam UMC, location 'AMC', Amsterdam, The Netherlands.
Data Analytics Research and Evaluation (DARE) Centre
Department of Critical Care Medicine, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Department of Intensive Care, Amsterdam UMC, location 'AMC', Amsterdam, The Netherlands.
Department of Critical Care Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal.
Department of Intensive Care, Vall d'Hebron Univerity Hospital, Barcelona, Spain; Ciber Enfermedades Respiratorias (CibeRes), Instituto de Salud Carlos III, Madrid, Spain.
Issue Date: 15-Sep-2022
Date: 2022
Publication information: Pulmonology 2022
Abstract: We determined the prevalences of hyperoxemia and excessive oxygen use, and the epidemiology, ventilation characteristics and outcomes associated with hyperoxemia in invasively ventilated patients with coronavirus disease 2019 (COVID-19).
URI: https://ahro.austin.org.au/austinjspui/handle/1/31626
DOI: 10.1016/j.pulmoe.2022.09.003
ORCID: 
Journal: Pulmonology
PubMed URL: 36274046
ISSN: 2531-0437
Type: Journal Article
Subjects: ARDS
COVID–19
Coronavirus disease 2019
Hyperoxemia
Invasive ventilation
Mortality
Normoxemia
Oxygen management
Ventilation
Appears in Collections:Journal articles

Show full item record

Page view(s)

52
checked on May 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.